Management Options for Persistent Postoperative Acromegaly

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


This article presents management options for the patient with acromegaly after noncurative surgery. The current evidence for repeat surgery, adjuvant medical therapy with somatostatin analogues, dopamine agonists, the growth hormone receptor antagonist pegvisomant, combination medical therapy, and radiotherapy in the context of persistent postoperative disease are summarized. The relative advantages and disadvantages of each of these treatment modalities are explored, and a general treatment algorithm that integrates these modalities is proposed.

Original languageEnglish (US)
Pages (from-to)621-638
Number of pages18
JournalNeurosurgery clinics of North America
Issue number4
StatePublished - Oct 2012


  • Acromegaly
  • Dopamine agonists
  • Growth-hormone adenoma
  • Persistent
  • Radiotherapy
  • Recurrent
  • Somatostatin analogues

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology


Dive into the research topics of 'Management Options for Persistent Postoperative Acromegaly'. Together they form a unique fingerprint.

Cite this